Skip to content

Research on the Effect of Chu Needle Combined with Aromatherapy on Nausea Caused by Platinum-based Chemotherapy Drugs

Research on the Effect of Chu Needle Combined with Aromatherapy on Nausea Caused by Platinum-based Chemotherapy Drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000470
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting

Interventions

Group A2:Aromatherapy Intervention
Group A3:Intervention of Chu Needle Combined with Aromatherapy
Group A1:Intervention of Chu Needle
Group A0:Emotional Nursing Care

Sponsors

West China School of Public Health (The Fourth Hospital of West China) Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria: 1) Inpatients undergoing chemotherapy who voluntarily sign the informed consent form and are willing to cooperate with this study. 2) Patients with malignant tumors that have been pathologically confirmed and meet the diagnostic criteria and who are planned to receive platinum - containing chemotherapy drugs for at least 2 cycles. 3) Age is between 18 and 80 years old (inclusive). 4) Karnofsky Performance Status (KPS) score is = 60 points and the expected survival period is > 3 months.

Exclusion criteria

Exclusion criteria: 2. Exclusion criteria: 1) Patients with mental disorders or cognitive impairment. 2) Patients with severe diseases of the heart liver kidneys etc. and those with severe dysfunction of these organs. 3) Patients with anorexia not caused by chemotherapy factors.

Design outcomes

Primary

MeasureTime frame
The incidence of nausea after chemotherapy;

Secondary

MeasureTime frame
appetite symptoms;

Countries

China

Contacts

Public Contactzouwei

West China School of Public Health (The Fourth Hospital of West China) Sichuan University

459681553@qq.com13699001973

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026